Electronic Prescribing of Controlled Substances (Final-Omit) was unanimously approved.
Jim Smith, regulatory analyst, explained the regulation would allow pharmacies to accept electronic prescriptions for Schedule II controlled substances, bringing them in line with Schedule III-V drugs. Smith said that following changes made by the federal Drug Enforcement Agency (DEA) and the state Department of Health (DOH), the regulation is the “last obstacle” in making Schedule II drugs available through electronic prescriptions. Smith noted the regulation was approved in the House and deemed approved in the Senate.
